The Orlucent® system has been tested in over 1000 patients.
Orlucent is conducting global clinical trials to identify transition thresholds in early tissue remodeling and to document the clinical impact of point of care non-invasive biological information in the management of moles.
For more information or if you are interested in participating in clinical trials or product evaluations, contact us at info@orlucent.com.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam. Lorem ipsum dolor sit amet.
Get updates on special events and receive your first drink on us!
©2024 Orlucent, Inc.
Los Gatos, California, USA
Contact: info@orlucent.com